Plumbline Life Sciences, Inc. Stock price

Equities

A222670

KR7222670002

Pharmaceuticals

End-of-day quote Korea S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
5,760 KRW -6.95% Intraday chart for Plumbline Life Sciences, Inc. -4.00% -4.64%
Dynamic Chart
Plumbline Life Sciences, Inc. announced that it has received KRW 500.12 million in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 500.12 million in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 500.12 million in funding CI
Plumbline Life Sciences, Inc. announced that it has received KRW 599.994 million in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 599.994 million in funding CI
Plumbline Life Sciences, Inc. announced that it has received KRW 50 million in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 50 million in funding CI
Plumbline Life Sciences, Inc. announced that it has received KRW 100 million in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 100 million in funding CI
Plumbline Life Sciences, Inc. announced that it has received KRW 110 million in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 110 million in funding CI
Plumbline Life Sciences, Inc. announced that it has received KRW 740 million in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 740 million in funding CI
Plumbline Life Sciences, Inc. announced that it has received KRW 1.2606 billion in funding CI
Plumbline Life Sciences, Inc. announced that it expects to receive KRW 1.2606 billion in funding CI
More news
1 day-6.95%
1 week-4.00%
Current month-3.03%
1 month-4.00%
3 months-6.19%
6 months-14.79%
Current year-4.64%
More quotes
1 week
5 620.00
Extreme 5620
6 200.00
1 month
5 490.00
Extreme 5490
6 840.00
Current year
5 050.00
Extreme 5050
6 840.00
1 year
4 650.00
Extreme 4650
8 050.00
3 years
3 515.00
Extreme 3515
8 800.00
5 years
3 515.00
Extreme 3515
11 500.00
10 years
3 515.00
Extreme 3515
13 250.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 13-12-31
Comptroller/Controller/Auditor 74 -
Comptroller/Controller/Auditor 45 -
Members of the board TitleAgeSince
Director/Board Member 69 -
Chief Executive Officer 53 13-12-31
Director/Board Member 52 17-03-29
More insiders
Plumbline Life Sciences, Inc. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of bio pharmaceuticals for animals using gene therapy. The Company provides small animal personalized medicines, infectious vaccines, growth hormone releasing hormone (GHRH), telomerase reverse transcriptase (TERT) and others. The Company's products are mainly used for pigs, cats, dogs, cows, horses and other animals.
More about the company
  1. Stock
  2. Equities
  3. Stock Plumbline Life Sciences, Inc. - Korea S.E.